GoodRx Announces Exclusive Low Cash Price for QSYMIA, the Leading Branded Once-Daily Oral Weight Management Medication for Adults
| GDRX Stock | USD 4.98 0.09 1.84% |
Slightly above 55% of Goodrx Holdings' investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Goodrx Holdings suggests that some traders are interested. Goodrx Holdings' investing sentiment can be driven by a variety of factors including economic data, Goodrx Holdings' earnings reports, geopolitical events, and overall market trends.
Goodrx |
GoodRx , the leading prescription savings platform in the U.S., announced today that QSYMIA phentermine and topiramate extended-releas
Read at businesswire.com
 |
Goodrx Holdings Fundamental Analysis
We analyze Goodrx Holdings' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Goodrx Holdings using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Goodrx Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Ratio
Current Ratio Comparative Analysis
Goodrx Holdings is currently under evaluation in current ratio category among its peers. Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Goodrx Holdings Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Goodrx Holdings stock to make a market-neutral strategy. Peer analysis of Goodrx Holdings could also be used in its relative valuation, which is a method of valuing Goodrx Holdings by comparing valuation metrics with similar companies.
Peers
Goodrx Holdings Related Equities
| HCAT | Health Catalyst | 6.38 | ||||
| TALK | Talkspace | 4.00 | ||||
| EVH | Evolent Health | 3.57 | ||||
| DOCS | Doximity | 1.51 | ||||
| HSTM | HealthStream | 1.50 | ||||
| VEEV | Veeva Systems | 1.43 | ||||
| TDOC | Teladoc | 0.63 | ||||
| NRC | National Research | 0.62 | ||||
| SDGR | Schrodinger | 0.27 | ||||
| ACCD | Accolade | 0.14 | ||||
| AMWL | American Well | 0.50 | ||||
| SLP | Simulations Plus | 0.79 | ||||
| TXG | 10X Genomics | 0.83 | ||||
| PGNY | Progyny | 1.53 | ||||
| PRVA | Privia Health | 1.92 | ||||
| GEHC | GE HealthCare | 2.29 | ||||
| CERT | Certara | 3.39 | ||||
| DH | Definitive Healthcare | 34.35 |
Additional Tools for Goodrx Stock Analysis
When running Goodrx Holdings' price analysis, check to measure Goodrx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Goodrx Holdings is operating at the current time. Most of Goodrx Holdings' value examination focuses on studying past and present price action to predict the probability of Goodrx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Goodrx Holdings' price. Additionally, you may evaluate how the addition of Goodrx Holdings to your portfolios can decrease your overall portfolio volatility.